Podcast – CFIDS research
Serum BAFF and APRIL Levels, T-Lymphocyte Subsets, and Immunoglobulins after B-Cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Myalgic Encephalopathy/Chronic Fatigue Syndrome
September 11, 2016
Continuation of the Rituximab trial in Norway. The modest increase in serum BAFF levels at baseline may indicate an activated B-lymphocyte system in a subgroup of ME/CFS patients.
We don't die, but we don't live either
Visit Podcast Website
RSS Podcast Feed
Subscribe
Share
Add to MyCast